NCT01692171 - Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Healthy

Interventions

DRUG

Heparin, Low-Molecular-Weight

single intravenous administration of 3mg/Kg of the test drug and the comparator drug, according to randomization, in a crossover design, each administration separated by 6 days of washout.

Trial Locations (1)

13271-130

LAL Clinica, Valinhos